Vaccine Tag

[wpseo_breadcrumb]

On June 10, 2021, the Occupational Safety and Health Administration (OSHA) updated its guidance on mitigating and preventing the spread of COVID-19 in the workplace.

The guidance applies to employers and employees in settings outside of the health care industry and is now focused only on protecting unvaccinated or otherwise at-risk employees in their workplaces. Employers can use this OSHA guidance to help them take the appropriate steps to prevent exposure and infection of unvaccinated or otherwise at risk employees.

[wpseo_breadcrumb]  

News Brief header U.S. health experts have identified an emerging strain of the coronavirus known as the Delta variant.

It was first seen in India, but has quickly moved across the globe. Experts predict it will soon be the dominant strain in the United States, already accounting for 10% of U.S. coronavirus cases. The good news is that existing COVID-19 vaccines seem to work well against the variant—drastically reducing the likelihood of hospitalization for vaccinated individuals.

[wpseo_breadcrumb]

Legal Update Header On May 18, 2021, the Los Angeles County Board of Supervisors passed an urgency ordinance requiring all private employers to provide paid leave for employees in unincorporated Los Angeles County for the purpose of receiving COVID-19 vaccinations.

The ordinance became effective immediately and is retroactive to Jan. 1, 2021. The leave requirement expires Aug. 31, 2021.

[wpseo_breadcrumb]

Legal Update Header On May 18, 2021, the Occupational Safety and Health Administration (OSHA) announced it is reviewing the U.S. Centers for Disease Control and Prevention (CDC) recommendations for fully vaccinated individuals.

OSHA has indicated it will update its Guidance on Mitigating and Preventing the Spread of COVID-19 in the Workplace and their National Emphasis Program for COVID-19 accordingly once the review is complete. Until then, the agency is referring employers to the CDC’s guidance for information on appropriate measures to protect fully vaccinated workers.

[wpseo_breadcrumb]

HR Insights Blog Header All adults in the United States are now eligible for COVID-19 vaccines. With vaccine distribution reaching the general public, a growing proportion of the workforce is now vaccinated.

In turn, many of these vaccinated employees have also received a vaccine card. It’s worthwhile for employers to understand what COVID-19 vaccine cards are and what uses they may have in the workplace. This article provides an overview of COVID-19 vaccine cards and considerations for supporting employees that have COVID-19 vaccine cards.

[wpseo_breadcrumb]

Legal Update Header On Apr. 20, 2021, the Occupational Safety and Health Administration (OSHA) provided guidance for recording COVID-19 vaccination adverse reactions.

The guidance comes in the format of frequently asked questions for adverse reactions under two scenarios: employer-required and voluntary vaccination.

Employer-required Vaccination

According to OSHA’s guidance, employers are required to record adverse reactions to the vaccine if the reactions are:

[wpseo_breadcrumb]

HR Insights Blog Header Employers play a critical role in helping promote and provide accurate information about COVID-19 vaccines.

Employees getting vaccinated can be a driving force for a safe return to work. As employers navigate the legal risks and logistics of return-to-work plans and employee vaccinations, this article explores considerations for increasing employee vaccine acceptance across their organizations.

[wpseo_breadcrumb]

News Brief header In a joint statement, the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have recommended lifting a pause on the distribution of the Johnson & Johnson (J&J) COVID-19 vaccine.

On April 13, the agencies recommended a pause on the J&J one-dose vaccine after reports of six cases of a rare and severe type of blood clot in individuals following administration of the vaccine. Reports of adverse events following the use of the J&J vaccine suggested an increased risk of a rare adverse event called thrombosis with thrombocytopenia syndrome (TTS). Nearly all reports of this serious condition, which involves blood clots with low platelets, have been in adult women under the age of 50.

[wpseo_breadcrumb]

News Brief header In a joint statement, the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have called for an immediate halt on the distribution of the Johnson & Johnson (J&J) COVID-19 vaccine.

The CDC’s Advisory Committee on Immunization Practices will meet on Wednesday, April 14, to further review these cases and assess their potential significance. Until that process is complete, the agencies are recommending a pause in the use of the J&J vaccine out of an abundance of caution.